These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27590630)

  • 1. A pH-Sensitive Nanocarrier for Tumor Targeting : Delivery of Ruthenium Complex for Tumor Theranostic by pH-Sensitive Nanocapsule.
    Chen L; Fu C; Deng Y; Wu W; Fu A
    Pharm Res; 2016 Dec; 33(12):2989-2998. PubMed ID: 27590630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer.
    Shen J; Kim HC; Wolfram J; Mu C; Zhang W; Liu H; Xie Y; Mai J; Zhang H; Li Z; Guevara M; Mao ZW; Shen H
    Nano Lett; 2017 May; 17(5):2913-2920. PubMed ID: 28418672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]
    Purushothaman B; Arumugam P; Ju H; Kulsi G; Samson AAS; Song JM
    Eur J Med Chem; 2018 Aug; 156():747-759. PubMed ID: 30048924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabricating β-cyclodextrin based pH-responsive nanotheranostics as a programmable polymeric nanocapsule for simultaneous diagnosis and therapy.
    Zarepour A; Zarrabi A; Larsen KL
    Int J Nanomedicine; 2019; 14():7017-7038. PubMed ID: 31564863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity, cellular uptake, and subcellular localization of a nitrogen oxide and aminopropyl-β-lactose derivative ruthenium complex used as nitric oxide delivery agent.
    Dos Santos JS; Ramos LC; Ferreira LP; Campo VL; de Rezende LCD; da Silva Emery F; Santana da Silva R
    Nitric Oxide; 2019 May; 86():38-47. PubMed ID: 30790696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
    Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
    Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
    Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
    J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium complex delivery using liposomes to improve bioactivity against HeLa cells via the mitochondrial pathway.
    Guo B; Liao C; Fang Y; Li S; Li X; Lu Z; Chen Y
    Nanomedicine (Lond); 2018 Nov; 13(22):2851-2866. PubMed ID: 30457036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carriers for metal complexes on tumour cells: the effect of cyclodextrins vs CNTs on the model guest phenanthroline-5,6-dione trithiacyclononane ruthenium(II) chloride.
    Braga SS; Marques J; Heister E; Diogo CV; Oliveira PJ; Paz FA; Santos TM; Marques MP
    Biometals; 2014 Jun; 27(3):507-25. PubMed ID: 24652595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agent.
    Valente A; Garcia MH; Marques F; Miao Y; Rousseau C; Zinck P
    J Inorg Biochem; 2013 Oct; 127():79-81. PubMed ID: 23896008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
    Pal M; Nandi U; Mukherjee D
    Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II) polypyridyl complexes: cellular uptake, cell image and apoptosis of HeLa cancer cells induced by double targets.
    Yu Q; Liu Y; Xu L; Zheng C; Le F; Qin X; Liu Y; Liu J
    Eur J Med Chem; 2014 Jul; 82():82-95. PubMed ID: 24878637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echogenic Gold Nanorod Incorporated Hybrid Poly(2-oxazoline) Nanocapsules for Real-Time Ultrasound/Fluorescent Imaging and Targeted Cancer Theranostics.
    Nehru S; Vergaelen M; Hoogenboom R; Sundaramurthy A
    ACS Appl Bio Mater; 2024 Jul; 7(7):4471-4485. PubMed ID: 38887037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    Popolin CP; Reis JPB; Becceneri AB; Graminha AE; Almeida MAP; Corrêa RS; Colina-Vegas LA; Ellena J; Batista AA; Cominetti MR
    PLoS One; 2017; 12(9):e0183275. PubMed ID: 28898246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium Complexes are pH-Activated Metallo Prodrugs (pHAMPs) with Light-Triggered Selective Toxicity Toward Cancer Cells.
    Qu F; Park S; Martinez K; Gray JL; Thowfeik FS; Lundeen JA; Kuhn AE; Charboneau DJ; Gerlach DL; Lockart MM; Law JA; Jernigan KL; Chambers N; Zeller M; Piro NA; Kassel WS; Schmehl RH; Paul JJ; Merino EJ; Kim Y; Papish ET
    Inorg Chem; 2017 Jul; 56(13):7519-7532. PubMed ID: 28636344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomeric selectivity of ruthenium (II) chiral complexes with antitumor activity, in vitro and in vivo.
    Zhang W; Sun Y; Wang J; Ding X; Yang E; Martin LL; Sun D
    J Inorg Biochem; 2021 Mar; 216():111339. PubMed ID: 33388703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities.
    Xu Z; Huang J; Kong D; Yang Y; Guo L; Jia X; Zhong G; Liu Z
    Eur J Med Chem; 2020 Dec; 207():112763. PubMed ID: 32882612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold nanorod-loaded thermosensitive liposomes facilitate the targeted release of ruthenium(II) polypyridyl complexes with anti-tumor activity.
    Zhu L; Kuang Z; Song P; Li W; Gui L; Yang K; Ge F; Tao Y; Zhang W
    Nanotechnology; 2021 Aug; 32(45):. PubMed ID: 34352731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.